Latest News
Cure SMA Announces Additional $315,000 for SMA Drug Program at The California Institute of Biomedical Research
Cure SMA is pleased to announce that we have extended our spinal muscular atrophy research program with the California Institute of Biomedical Research (CALIBR) with an additional $315,000 drug discovery […]
Read More ›Cure SMA Releases Updated Overview of Research Model
When Cure SMA first started funding research thirty years ago, we had to build up from virtually nothing. It’s no easy task. Drug development relies on volume to be successful—just […]
Read More ›Cure SMA Hosts SMA Researcher Meeting this June
The Annual SMA Conference consists of two separate events that run in parallel. The first is focused on families affected by SMA, who gather for workshops, keynote sessions, networking, and […]
Read More ›How Our Cure SMA Community is Raising Awareness
Spinal muscular atrophy is the number one genetic cause of death for infants, and 1 in 50 people carry the genetic mutation that causes SMA. But even so, many people […]
Read More ›Cure SMA Annual Campaign Sets $1 Million Goal
When our year-end campaign began in mid-November, we set an initial goal of raising $540,000. Our community quickly met that challenge, so we increased our goal to $750,000—the most ever […]
Read More ›Updates on Pharmaceutical Companies Investing in SMA Drug Development
Over the past decade, one of the most important advances in SMA drug development has been the number of pharmaceutical companies investing in treatments for SMA. Ten years ago, we […]
Read More ›